Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 1/Phase 2 study evaluating the use of umbilical cord-derived mesenchymal stromal cells to treat severe steroid-resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Umbilical cord-derived mesenchymal stromal cells (umbilical cord-derived mesenchymal stromal cells)

Snippet

Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: Hematologic Malignancies | Phase 1, Phase 2 | Status: UNKNOWN